Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • India: The Next Big Manufacturing Superpower Business
  • Mirchi Ad World – One Stop Solution for Autorickshaw and Outdoor Branding Business
  • India’s biggest men’s pageant – Rubaru Mr. India returns with an all-new season English
  • Usha Breco Foundation organises tourist guide training programme in Junagadh Business
  • Assam Rifles’ Women Shine in 7th All India Police Judo Cluster -2022 Business
  • Zikrr Band – A Musical Journey through the Decade Entertainment
  • Peakst8 Festival Redefines Fitness as Shared Culture, Not Competition, Rainmatter’s Vision for a Healthier India Lifestyle
  • Toshiba Unveils C350NP Smart Google TV with Dolby Vision and Atmos Starting at INR 26,999 Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • WHP report shows 25% COVID-19 patients still affected with mental health issues Business
  • SEPC Limited Wins INR 230 Crore Turnkey Mining Infrastructure Order from MOIL Limited Business
  • ITC Nimyle’s “Shuddh Shuruat’’: An Initiative to cleanse the Rath Yatra’s path with Neem based Nimyle Business
  • Future Generali India Life Nears Breakeven; FY25 Individual New Business Premium Up 19% to Rs 476 Cr Business
  • The Ultimate Guide to Simplifying Name Change Ads with Ads2publish.com Business
  • Worlds First Hybrid STP inaugurated by Miss Universe India Divita Rai for Huliot India Business

Recent Posts

  • VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share
  • VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share
  • eYantra Ventures Limited Reports FY26 Annual Results
  • eYantra Ventures Limited Reports FY26 Annual Results
  • VMS TMT Limited Announces Q4 FY26 and FY26 Results

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Reconnect with Nature and Your Inner Peace at Utopiaa Managed Farmlands National
  • BIBA Girls Lights Up the Runway at India Kids Fashion Week Season 11, Delhi Lifestyle
  • Mr. Venkat Kalyan Chivukula Recognized as Emerging CEO of the Year at the World Telugu IT Conference Lifestyle
  • Mughal-E-Azam Revived: Tuli Research Centre for India Studies Presents Self-Discovery Exhibition National
  • Tech Kodainya Brings Vibe Coding to Enterprise Development, Accelerating Delivery for Customers Technology
  • SBI CME Soldierathon 3.0 Concludes with Record Participation and Inspiring Displays of Patriotism National
  • Whether Fire Safety And Evacuation Solutions are a Luxury or Necessity National
  • ACTIZEET Issues Guidelines to Help Consumers Identify Original Shilajit Health

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme